These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9704091)

  • 1. Artificial cells with emphasis on bioencapsulation in biotechnology.
    Chang TM
    Biotechnol Annu Rev; 1995; 1():267-95. PubMed ID: 9704091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial cells in immobilization biotechnology.
    Chang TM
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(5):1121-43. PubMed ID: 1457687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial cells: 35 years.
    Chang TM
    Artif Organs; 1992 Feb; 16(1):8-12. PubMed ID: 1338616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial cell biotechnology for medical applications.
    Chang TM
    Blood Purif; 2000; 18(2):91-6. PubMed ID: 10838466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial cells for cell and organ replacements.
    Chang TM
    Artif Organs; 2004 Mar; 28(3):265-70. PubMed ID: 15046625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial cells with emphasis on cell encapsulation of genetically engineered cells.
    Chang TM
    Artif Organs; 1998 Nov; 22(11):958-65. PubMed ID: 9821530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial cells for replacement of metabolic organ functions.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):151-61. PubMed ID: 12751835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology.
    Chang TMS
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):997-1013. PubMed ID: 30945957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial cells in medicine and biotechnology.
    Chang TM
    Appl Biochem Biotechnol; 1984; 10():5-24. PubMed ID: 6395808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial cells, encapsulation, and immobilization.
    Chang TM
    Ann N Y Acad Sci; 1999 Jun; 875():71-83. PubMed ID: 10415559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of artificial cells in medicine and biotechnology.
    Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(1):1-20. PubMed ID: 3329537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial cells and bioencapsulation in bioartificial organs.
    Chang TM
    Ann N Y Acad Sci; 1997 Dec; 831():249-59. PubMed ID: 9616717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present status of modified hemoglobin as blood substitutes and oral therapy for end stage renal failure using artificial cells containing genetically engineered cells.
    Chang TM
    Ann N Y Acad Sci; 2001 Nov; 944():362-72. PubMed ID: 11797686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
    Chang TM
    Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial cells as bioreactive biomaterials.
    Chang TM
    J Biomater Appl; 1988 Jul; 3(1):116-25. PubMed ID: 3058929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic uses of microencapsulated genetically engineered cells.
    Chang TM; Prakash S
    Mol Med Today; 1998 May; 4(5):221-7. PubMed ID: 9612802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial cells in hemoperfusion and other applications.
    Chang TM
    Nephron; 1984; 36(3):161-8. PubMed ID: 6366599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria.
    Chang TM; Bourget L; Lister C
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(1):1-21. PubMed ID: 7719440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiscale requirements for bioencapsulation in medicine and biotechnology.
    de Vos P; Bucko M; Gemeiner P; Navrátil M; Svitel J; Faas M; Strand BL; Skjak-Braek G; Morch YA; Vikartovská A; Lacík I; Kolláriková G; Orive G; Poncelet D; Pedraz JL; Ansorge-Schumacher MB
    Biomaterials; 2009 May; 30(13):2559-70. PubMed ID: 19201460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prometheus: from legend to the real liver support therapy.
    Rifai K; Tetta C; Ronco C
    Int J Artif Organs; 2007 Oct; 30(10):858-63. PubMed ID: 17992646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.